Cabrini Research Annual Report 2020-21 Publications and grants
Monash-Cabrini Department of Clinical Epidemiology Grants NHMRC Program Grant. ‘Musculoskeletal pain and disability: improving outcomes through conservation interventions’. ID 1091302. (2016-2020), $8,268,140 Hodges P, Bennel K, et al. Buchbinder R (AI). NHMRC Partnership Grant. ‘Patient-centred eHealth approach to improving outcomes for gout sufferers’. (2016-2020), $660,656 Day R, et al. Buchbinder R (AI). NHMRC Program Grant. ‘Using healthcare wisely: reducing inappropriate use of tests and treatments’. APP1113532. (2017-2021), $9,578,895 Glasziou P, Buchbinder R, Maher C, McCaffery K. ‘NHMRC Partnership Centre in Health System Sustainability’. (2017-2022), $10,700,000 (NHMRC $5,250,000; Partners: Bupa Health Foundation, NSW Health, Telstra and the University of Notre Dame Australia) Braithwaite J, Ward RL, Anderson T, Teede H, Wells L, Gray LC, Yeend T, Coiera E, Westbrook J, Glasziou P, Scott A, Karnon JD, Buchbinder R. NHMRC Project Grant. ‘SUcceSS: SUrgery for Spinal Stenosis – a randomised placebo-controlled trial’. APP1125140. (2017-2021), $2,300,000 Ferreira M, Harris I, Davis G, Latimer J, Beard D, Li Q, Mobbs R. AIs: Buchbinder R, [formerly CIB but changed to AI in view of successful Program Grant]. NHMRC Centre of Research Excellence. ‘ANZMUSC – Australia and New Zealand Musculoskeletal Clinical Trials Network’. APP1134856. (2018-2022), $2,497,653 Buchbinder R, Maher C, March L, Day R, Hinman R, Harris I, Ferreira M, Glasziou P, Green S, Billot L. NHMRC Medical Research Future Fund (MRFF) Research Grant. ‘CRISTAL: Cluster randomised trial of aspirin versus Low molecular weight heparin for venous thromboembolism prophylaxis in joint replacement surgery, a registry-nested study’. APP1152285. (2018-2022), $910,700 Harris I, Graves S, Buchbinder R, Naylor J, Pratt N, de Steiger R, Chong B, Ackerman I, Harris A. Academy of Finland. ‘Finnish Imaging of Degenerative Shoulder Study (FIMAGE): A study on the prevalence of degenerative imaging changes of the shoulder and their relevance to clinical symptoms in the general population’. (2018-2022), $450,000 Taimela S, et al.
120
NHMRC Project Grant. ‘Trial of glucocorticoids in acute sciatica’. APP1157835. (2019-2022), $1,142,038 Lin CWC, McLachlan A, Latimer J, Abdel Shaheed C, Li Q. Buchbinder R (AI) [formerly CI but changed to AI in view of successful Program Grant]. Australian Government Department of Health. ‘Value in Prescribing Program: Biological disease modifying antirheumatic drugs (bDMARDs): Value-based prescribing of bDMARDs: a coordinated national program’. (20192022), $8,411,403 Partnership between: NPS MedicineWise (Dartnell J, London J, Heaney A, Hosking K, Yoo J, Elliott J, Granger R, Blogg S, Antonio G), ARA (Hill C, Barrett C, Morabani M, Kubler P, Day R, Clancy M, Buchbinder R [also representing ANZMUSC and Cochrane Musculoskeletal]), ANZMUSC (Whittle S, O’Connor D), Cochrane Musculoskeletal (Johnston R), Arthritis Australia (Mills A, Marine F), Quality Use of Medicines and Pharmacy Research Centre (Rowett D, Roughead L, Ward M, Wiese M), Pharmaceutical Society of Australia (Jackson S, Freeman C, McMaugh J, Ridd J), Society of Hospital Pharmacists of Australia (Michaels K, Jerry Yik J, Hayward K), Council of Australian Therapeutic Advisory Groups (Etherton-Beer C, Donnelly J, Bennett S). Therapeutic Guidelines LTD (TGL)/RACGP Foundation Research Grant (TGL -03). ‘Use of osteoarthritis guidelines in general practice: An analysis of work-as-done using the functional resonance analysis method’. (2019-2021), $19,968 Stocks N, Whittle S, Clay-Williams, Buchbinder R. ‘NHMRC Low Back Pain Centre for Research Excellence (CRE)’. APP1171459. (2020-2024), $2,499,189 Maher C, Buchbinder R, Hancock M, O’Sullivan P, McAuley J, Blyth F, Jorm L, Collie A, McCaffery K, Hayes A (AI O’Connor D). Arthritis Australia Grant-in-Aid. ‘The development of a patient decision aid to reduce subacromial decompression’. (2020), $15,000 Zadro J, Maher C, Buchbinder R, Harris I. NHMRC. The Cochrane Collaboration Round 8 Funding Program. ‘Cochrane Musculoskeletal Review Group, Australian Editorial base’. (2020-2023), $384,204 Buchbinder R, Johnston R, O’Connor D, Winzenberg T, Maher C, Whittle S. Australian Government Department of Health. ‘Public Health and Chronic Disease Program Arthritis – Health Professional Education and Training’. (2020-2023), $2,018,464 Partnership between: Arthritis Australia, University of Sydney, University of Melbourne, Arthritis and Osteoporosis Australia in partnership with Curtin University, Monash University on behalf of ANZMUSC and Cochrane Musculoskeletal, Australian Rheumatology Association.
